Isaacs' syndrome (autoimmune neuromyotonia) in a patient with systemic lupus erythematosus

Journal of Rheumatology

Volumn 32, Issue 4, 2005, Pages 757-758

  Taylor, Philip W ^a,b  

^a Cape Girardeau Physician Associates   (United States)

^b NONE   (United States)

Author keywords

Autoimmune neuromyotonia; Channelopathy; Isaacs' syndrome; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CLONAZEPAM; GABAPENTIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VOLTAGE GATED POTASSIUM CHANNEL;

ABDOMINAL WALL MUSCULATURE; ADULT; ANTIBODY PRODUCTION; ARM MUSCLE; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FACE MUSCLE; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; LABORATORY TEST; LEG MUSCLE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MUSCLE CRAMP; MUSCLE TWITCH; MYOKYMIA; PATIENT COMPLIANCE; PERIPHERAL NERVE; PLASMAPHERESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SKELETAL MUSCLE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT INDICATION;

AMINES; ANTICONVULSANTS; AUTOANTIBODIES; AZATHIOPRINE; CLONAZEPAM; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; ISAACS SYNDROME; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MIDDLE AGED; POTASSIUM CHANNELS, VOLTAGE-GATED; PREDNISONE;

EID: 17144406866     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-25.
2. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): Report of 5 cases and literature review. Brain 1993;116:453-69.
3. Lindstrom JM, Seybold ME, Lennon VA, Whittinghan S, Duane KK. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology 1976;26:1054-9.
4. Lang B, Newsom-Davis J, Wray D, Vincent A, Murray NMF. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2:224-6.
5. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-46.
6. Hart IK. Acquired neuromyotonia: A new autoantibody-mediated neuronal potassium channelopathy. Am J Med Sci 2000;319:209-16.
7. Reeback J, Benton S, Swash M, et al. Penicillamine-induced neuromyotonia. BMJ 1979;279:1464-5.
8. Benito-Leon J, Miguelez R, Vincent A, Masjuan J, de Blas G. Neuromyotonia in association with systemic sclerosis. J Neurol 1999;246:976-7.
9. Le Gars L, Clerc D, Cariou D, Lavabre C, Metral S, Bisson M. Systemic juvenile rheumatoid arthritis and associated Isaacs' syndrome. J Rheumatol 1997;24:178-80.
10. Oh SJ, Alapati A, Claussen GC, Vernino S. Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies. Muscle Nerve 2003;27:757-60.
11. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887-95.
12. Newsom-Davis J. Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy. Ann N Y Acad Sci 1997;835:111-9.
13. Browne D, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene KCNA1. Nat Genet 1994;8:136-40.
14. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94:184-92.
15. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.